Eugene Y Chiang

5PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursCybercrime
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 05, 2022
TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy.

Eugene Y Chiang, Ira Mellman

|Feb 12, 2020
CD96 functions as a co-stimulatory receptor to enhance CD8+ T cell activation and effector responses.

Eugene Y Chiang, Patricia E de Almeida, Denise E de Almeida Nagata

Pageof 1